KRKA, tovarna zdravil, d.d., Novo mesto earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2024 | 2024-12-31 | €11.60 | €11.60 | 2026-06-19T15:07:19Z |
| 2023 | 2023-12-31 | €10.14 | €10.14 | 2026-06-19T15:07:19Z |
Revenue & profit (EUR)
| Concept | 2024 | 2023 |
|---|---|---|
| Revenue | €1.91B | €1.81B |
| Profit for the year | €356.2M | €313.7M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in KRKA, tovarna zdravil, d.d., Novo mesto's ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.